SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

Search

Eurofins Scientific SE

Închisă

69.98 1.13

Rezumat

Modificarea prețului

24h

Curent

Minim

69.86

Maxim

70.58

Indicatori cheie

By Trading Economics

Venit

105M

228M

Vânzări

1.9B

3.7B

P/E

Medie Sector

25.451

76.004

EPS

1.221

Randament dividend

1.12

Marjă de profit

6.2

Angajați

65,694

EBITDA

285M

693M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+10.75% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.12%

3.34%

Statistici piață

By TradingEconomics

Capitalizare de piață

-1.1B

11B

Deschiderea anterioară

68.85

Închiderea anterioară

69.98

Scor tehnic

By Trading Central

Încredere

Weak Bearish Evidence

Eurofins Scientific SE Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 apr. 2026, 20:26 UTC

Achiziții, Fuziuni, Preluări

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 apr. 2026, 18:15 UTC

Evenimente importante

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 apr. 2026, 16:49 UTC

Evenimente importante

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17 apr. 2026, 16:49 UTC

Evenimente importante

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17 apr. 2026, 22:58 UTC

Câștiguri

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 apr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 apr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 apr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17 apr. 2026, 20:52 UTC

Câștiguri

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 apr. 2026, 20:50 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

17 apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 apr. 2026, 20:29 UTC

Câștiguri

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 apr. 2026, 19:34 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

17 apr. 2026, 19:34 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 apr. 2026, 19:31 UTC

Market Talk
Evenimente importante

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 apr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17 apr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 apr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 apr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 apr. 2026, 18:57 UTC

Evenimente importante

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 apr. 2026, 18:53 UTC

Achiziții, Fuziuni, Preluări

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 apr. 2026, 18:53 UTC

Achiziții, Fuziuni, Preluări

UCB 2026 Rev Guidance Unchanged

17 apr. 2026, 18:52 UTC

Achiziții, Fuziuni, Preluări

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 apr. 2026, 18:52 UTC

Achiziții, Fuziuni, Preluări

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 apr. 2026, 18:14 UTC

Market Talk
Evenimente importante

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 apr. 2026, 18:00 UTC

Evenimente importante

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 apr. 2026, 18:00 UTC

Evenimente importante

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 apr. 2026, 17:31 UTC

Market Talk
Evenimente importante

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 apr. 2026, 17:26 UTC

Market Talk
Câștiguri

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Comparație

Modificare preț

Eurofins Scientific SE Așteptări

Obiectiv de preț

By TipRanks

10.75% sus

Prognoză pe 12 luni

Medie 77.35 EUR  10.75%

Maxim 81 EUR

Minim 73.7 EUR

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEurofins Scientific SE - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

1

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

54.22 / 56.82Suport & Rezistență

Termen scurt

Weak Bearish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat